![]() |
市場調查報告書
商品編碼
2034963
全球靜脈通路裝置市場:市場規模、佔有率和趨勢分析(2026-2032 年)Vascular Access Device Market Size, Share, & Trends Analysis | Global | 2026-2032 | Includes: Implantable Port Market, Central Venous Catheter Market, and 11 more |
||||||
※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。
2025年全球靜脈通路裝置市場規模為130億美元。預計到2032年,該市場將以2.4%的年複合成長率成長,達到約153億美元。
本報告涵蓋靜脈通路裝置,包括植入式輸液港、輸液港針、中心靜脈導管 (CVC)、經外周靜脈置入中心靜脈導管 (PICC)、經外周靜脈置入中心靜脈導管 (PIVC)、外用輸液導管 (EDC)、中線導管、透析導管、導管尖端定位系統、導管固定裝置、抗菌貼片、導管固定裝置、抗菌貼片、導管固定裝置和注射器。
分析內容包括銷售量、平均售價 (ASP)、治療次數、市場規模、市場佔有率、成長趨勢、到 2032 年的市場預測以及到 2022 年的歷史數據。
市場成長主要受以下因素驅動:向電動輸液裝置的轉變、安全產品的普及以及向高附加價值血管通路技術的逐步過渡。然而,培訓要求和感染風險仍然限制了某些領域對這些技術的採用。
市場概覽
全球靜脈通路裝置市場涵蓋了廣泛的產品,這些產品可為藥物輸注、血液採集、造影劑注射、透析、液體療法和長期治療途徑提供靜脈通路。
該市場涵蓋了高劑量、短週期產品,例如周邊靜脈導管 (PIVC)、注射器和針頭,以及高價值產品,例如植入式輸液港、經靜脈中央靜脈導管(PICC)、中線導管和先進的固定系統。如此廣泛的產品範圍反映了血管通路在醫院、門診和慢性病護理機構中發揮的核心作用。
市場成長更多是由產品組合的變化而非單純的銷售擴張所驅動。高價值、更複雜的設備在市場總價值中的佔有率正逐步提升,而短期使用產品的需求趨勢則趨於成熟。
產品組合的這種轉變持續支撐著整體市場價值的成長,儘管不同地區的接受度有所差異。在已開發市場,具備先進安全特性、高壓輸注能力和先進留置技術的產品更容易被接受,而在新興市場,更基礎的血管通路產品可能會繼續擴大市場覆蓋範圍。
市場促進因素
過渡到可注入式電源
高壓注射裝置的轉變是血管通路市場的主要驅動力。許多長期靜脈通路裝置,包括輸液港、中心靜脈導管和經外周靜脈置入中心靜脈導管,現在都提供高壓注射規格,以滿足電腦斷層掃描(CT)造影劑輸送的要求。
這些設備的定價高於傳統產品。隨著醫院對CT掃描的需求增加,以及能夠處理造影劑注射的靜脈通路裝置的需求上升,市場需求正轉向更高規格的產品。
高壓注射相容型設備的轉型將有助於提升整體銷量,同時也有助於維持平均售價 (ASP)。這在成熟市場尤其重要,因為僅靠銷售成長可能不足以推動市場強勁擴張。
過渡到安全產品
轉向使用安全產品是另一個重要的促進因素。許多國家已頒布法律,強制要求使用安全裝置,以減少醫護人員和病患的針刺傷事故。
這些標準要求雇主識別風險、評估更安全的醫療設備、保存銳器傷亡記錄,並讓醫療專業人員參與安全產品的選擇。因此,安全裝置已成為多種血管通路類別的標準配備。
在某些領域,例如急診護理中的周邊靜脈置管(PIVC),已經實現了較高的普及率。然而,全球範圍內的轉型尚未完成。許多國家尚未實施嚴格的安全要求,這為未來採用價格更高的安全產品留下了空間。
向高附加價值設備過渡
市場成長也得益於高附加價值血管通路產品的偏好轉變。植入式輸液港、PICC導管、中線導管和先進的固定解決方案在市場總值中所佔佔有率正逐步擴大。
這些產品通常具有延長留置時間、改善工作流程、增強患者管理或專門用於腫瘤學、液體療法、透析和長期照護等優點。
這種轉變將使銷售量大的產品類型即使在成熟階段也能維持其市場價值。隨著醫院採用更先進的血管通路策略,產品組合將持續成為2032年之前的主要成長要素。
市場限制
教育和培訓
教育和培訓要求仍然是血管通路市場成長的限制因素。新型血管通路產品通常需要對醫護人員進行培訓,以確保正確使用。
培訓既費錢又費時。雖然護理人員對學習如何使用新的血管通路技術很感興趣,但醫生們不願意接受培訓,往往更傾向於使用他們已經熟悉的設備。
如果培訓不到位,新設備的引入可能會受到限制。這會影響到尖端定位系統、動力輸液裝置和新型導管技術等先進產品。對於這些產品而言,正確使用對於安全性、工作流程和治療效果至關重要。
感染率高
感染風險仍然是重要的阻礙因素,尤其是在中心靜脈通路方面。由於靜脈通路裝置可能成為感染途徑,因此中心靜脈通路通常僅在其他選擇無效時才會使用。
與動靜脈瘻管和動靜脈移植相比,透析導管的感染率較高。只要有感染率較低的替代方案,某些靜脈通路裝置的使用就可能受到限制。
這種風險也增加了對抗菌導管貼片、固定裝置和導管帽等感染預防配件的需求。然而,感染的潛在風險依然存在,這可能會限制某些導管通路方式的廣泛應用。
成熟的高銷售市場
幾種高容量血管通路產品類別已經成熟。諸如外周靜脈留置針、注射器和針頭等傳統產品已被廣泛使用,並在許多醫療系統中得到應用。
在這些細分市場中,成長往往受到競爭、採購壓力和差異化不足的限制。即使銷量很高,實現平均售價 (ASP) 的成長也並非易事。
因此,整體市場擴張不僅嚴重依賴基本的大眾市場產品,而且還依賴高階設備、增強的安全功能、電子產品以及涉及更複雜類別的產品。
市場覆蓋範圍和數據範圍
目標市場及區隔
長期留置導管市場是作為更廣泛的靜脈通路裝置市場的一部分進行分析的。
本部分介紹用於輔助精確血管通路放置的系統和配件。
本部分重點在於降低導管插入部位周圍感染風險的貼片。
本部分重點在於血管通路管理中使用的導管帽。
每個細分市場都按市場規模、市場佔有率、治療數量、市場預測、市場成長率、銷售量和平均售價進行分析。
競爭分析
2025年,貝克頓·迪金森公司(BD)在全球靜脈通路裝置及配件市場佔據領先地位。該公司在其核心靜脈通路裝置和配件產品類型中均保持了強大的市場地位。
BD公司透過拓展產品組合和整合先進的臨床解決方案,不斷鞏固其市場地位。本公司廣泛的醫院產品涵蓋血管通路、感染預防、工作流程最佳化和生命維持等領域。
持續的產品創新鞏固了BD在報告涵蓋的大多數細分市場的領先地位。公司的規模、與臨床機構的合作以及豐富的產品系列,都為其在成熟市場和高成長市場的競爭力提供了有力支撐。
憑藉廣泛的周邊和中心靜脈通路解決方案產品組合,B. Braun 在 2025 年仍然是領先的競爭對手之一。該公司在 PIVC 和 CVC 系統方面擁有強大的影響力,並為心電圖引導的尖端定位提供整合支援。
貝朗公司也進軍植入式輸液港和輸液港穿刺針領域,進一步鞏固了企業發展。此外,該公司還在注射器和針頭領域建立了穩固的地位,儘管規模較小。
康德樂公司主要透過注射器、針頭和部分導管固定產品參與市場競爭。憑藉其作為全球製造商和分銷商的規模優勢,康德樂在向醫院和居家醫療機構供應大批量耗材方面保持著強大的市場地位,同時在更為複雜的靜脈通路裝置領域涉足較少。
科技和醫療治療的發展趨勢
電動注射裝置的廣泛應用
隨著CT造影劑使用量的增加,電動注射端口、中心靜脈導管(CVC)和經周邊靜脈置入中心靜脈導管(PICC)的重要性日益凸顯。這些設備能夠支援影像工作流程,且平均售價(ASP)高於傳統產品。
使用量的增加正在將市場價值轉移到高階、長期使用的接取設備。
過渡到安全裝置
安全裝置有望成為許多血管通路手術的標準治療方法。法律要求和預防事故的措施正在推動這一轉變。
未來在安全法規較為寬鬆的國家實施該方案,可能會帶來進一步的成長。
導管尖端定位支撐
隨著醫療專業人員更加重視精確放置導管和簡化工作流程,導管尖端定位系統及相關配件的重要性日益凸顯。
這些系統可以減少置入過程中的不確定性,並支援更一致的血管通路操作。
感染預防
感染預防仍是血管通路照護的核心挑戰。抗菌導管貼片、導管帽和固定產品有助於降低感染風險,確保更安全的通路管理。
這一趨勢在中心靜脈通路和透析通路中尤其重要。
長期准入的成長
植入式輸液港、PICC導管和中線導管等高價值醫療器材在整個市場中的重要性日益凸顯。這些產品能夠滿足更長的植入週期和更專業的治療需求。
這種成長反映了從基本的、短期的獲取方式轉變為更個人化的獲取策略。
成熟消費品市場的競爭
諸如外周靜脈留置針、注射器和針頭等大批量耗材的需求已趨於成熟,並面臨巨大的價格壓力。在這些品類中競爭的公司必須管理好銷售量、採購預期和安全轉型。
這一趨勢抑制了基礎產品類型平均售價 (ASP) 的成長。
地區
本報告提供了涵蓋北美、歐洲、亞太地區、拉丁美洲以及中東和非洲的全球研究成果。
iData Research 的《全球靜脈通路裝置市場報告》透過裝置層級分析、基於手術的建模、平均售價 (ASP) 數據、企業市場占有率分析以及到 2032 年的預測來解答這些問題。該報告可用於評估全球靜脈通路裝置市場的需求、比較競爭對手、了解不斷變化的產品組合以及製定產業計畫。
全球血管通路市場概覽
競爭分析
市場趨勢
市場趨勢
目標程式
目標市場
目標區域
主要報告更新
版本歷史記錄
全球血管通路市場概覽
The global vascular access device market was valued at $13 billion in 2025. It is expected to grow at a compound annual growth rate (CAGR) of 2.4%, reaching nearly $15.3 billion by 2032.
This report covers the global market for vascular access devices and accessories, including implantable ports, port needles, CVCs, PICCs, PIVCs, EDCs, midlines, dialysis catheters, tip-placement systems, catheter securement, antibacterial patches, catheter caps, syringes, and needles.
The analysis includes unit sales, average selling prices (ASPs), procedure numbers, market size, market shares, growth trends, market forecasts through 2032, and historical data back to 2022.
Market growth is supported by conversion to power-injectable devices, conversion to safety products, and a gradual shift toward higher-value vascular access technologies. However, training requirements and infection risk continue to limit adoption in certain segments.
Market Overview
The global vascular access device market includes a broad set of products used to provide venous access for medication delivery, blood draws, contrast injection, dialysis, infusion therapy, and longer-term treatment pathways.
The market includes both high-volume short-term products, such as PIVCs, syringes, and needles, and higher-value products, such as implantable ports, PICCs, midlines, and advanced securement systems. This wide scope reflects the central role of vascular access across hospital, outpatient, and chronic care settings.
Growth in the market is being driven more by shifts in product mix than by pure volume expansion. Higher-value and more complex devices are gradually accounting for a larger share of total market value, while short-term products face more mature demand dynamics.
This mix shift continues to support overall market value growth, although adoption varies across regions. Developed markets are more likely to adopt premium safety, power-injectable, and advanced placement technologies, while emerging markets may continue expanding access through more basic vascular access products.
Market Drivers
Conversion to Power-Injection
Conversion to power-injectable devices is a major driver of the vascular access market. Many long-term vascular access devices, including ports, CVCs, and PICCs, are now available in power-injectable configurations required for computed tomography contrast media.
These devices carry a price premium over conventional alternatives. As hospitals increase their use of CT imaging and require vascular access devices that can support contrast injection, demand is shifting toward higher-value configurations.
The transition to power-injectable devices supports growth in overall unit sales while helping sustain ASPs. This is especially important in mature segments where volume growth alone may not be enough to drive strong market expansion.
Conversion to Safety Products
Conversion to safety products is another important driver. Many countries have implemented legislation requiring the use of safety devices to reduce needlestick injuries among healthcare workers and patients.
These standards require employers to identify risks, evaluate safer medical devices, maintain sharps injury logs, and involve healthcare workers in selecting safety products. As a result, safety devices have become the standard in several vascular access categories.
Some segments, such as PIVCs in acute care settings, have already achieved high conversion rates. However, the global transition is not complete. Many countries have yet to implement strong safety requirements, leaving room for future adoption of premium-priced safety products.
Shift Toward Higher-Value Devices
The market is also being supported by a shift toward higher-value vascular access products. Implantable ports, PICCs, midlines, and advanced securement solutions are gradually accounting for more of total market value.
These products often provide longer dwell times, improved workflow, better patient management, or specialized use in oncology, infusion therapy, dialysis, or long-term care.
This shift helps sustain market value even when high-volume product categories mature. As hospitals adopt more advanced vascular access strategies, product mix will remain a key driver through 2032.
Market Limiters
Education and Training
Education and training requirements continue to limit growth in the vascular access market. New vascular access products often require staff training to ensure proper use.
Training can be expensive and time consuming. Nurses have shown interest in learning how to use new vascular access technologies, but physicians may be more reluctant to receive training and often prefer devices they already know.
If proper training is not completed, adoption of new devices can be limited. This affects advanced products such as tip-placement systems, power-injectable devices, and newer catheter technologies where correct use is important to safety, workflow, and outcomes.
High Infection Rate
Infection risk remains an important limiter, especially in central venous access. Vascular access devices can create a pathway for infection, and central venous access is often used only when other options are not sufficient.
Dialysis catheters have higher infection rates than arteriovenous fistulae or AV grafts. As long as alternatives with lower infection rates are available, use of certain vascular access devices may be limited.
This risk also increases demand for infection prevention accessories, including antibacterial catheter patches, securement devices, and catheter caps. However, the underlying infection risk can still limit broader adoption of certain access methods.
Mature High-Volume Segments
Several high-volume vascular access categories are mature. Products such as conventional PIVCs, syringes, and needles are widely used and already have established adoption across many healthcare systems.
In these segments, growth is often constrained by price competition, procurement pressure, and limited differentiation. Even when unit volumes remain high, ASP growth can be difficult to achieve.
As a result, overall market expansion depends more heavily on premium devices, safety conversion, power-injectable products, and higher-complexity categories rather than basic high-volume products alone.
Market Coverage and Data Scope
Markets Covered and Segmentation
The extended dwell catheter market is analyzed as part of the broader vascular access device market.
This segment covers systems and accessories used to support accurate vascular access placement.
This segment covers patches used to reduce infection risk around catheter insertion sites.
This segment covers catheter caps used as part of vascular access management.
Each segment is analyzed by market size, market shares, procedure numbers, market forecasts, market growth rates, units sold, and average selling prices.
Competitive Analysis
In 2025, Becton Dickinson led the global vascular access device and accessories market. The company maintained a strong presence across both core vascular access devices and adjunct product categories.
BD has continued to strengthen its position through portfolio expansion and integration of advanced clinical solutions. Its broader hospital offering includes vascular access, infection prevention, workflow efficiency, and critical care support.
Ongoing product innovation has reinforced BD's leadership across most segments covered in this report. The company's scale, clinical relationships, and broad vascular access portfolio support its competitiveness in both mature and higher-growth categories.
B. Braun remained one of the leading competitors in 2025, supported by a broad portfolio spanning peripheral and central access solutions. The company has a strong presence in PIVCs and CVC systems, with integrated support for ECG-guided tip positioning.
B. Braun also participates in implantable ports and port access needles, strengthening its exposure across multiple vascular access segments. The company maintains a smaller but established footprint in syringes and needles.
Cardinal Health competed primarily through syringes and needles and selected catheter securement products. Leveraging its scale as a global manufacturer and distributor, Cardinal Health maintains a strong presence in high-volume consumables supplied to hospitals and alternate-site care settings, while remaining less exposed to higher-complexity vascular access device segments.
Technology and Practice Trends
Power-Injectable Device Adoption
Power-injectable ports, CVCs, and PICCs are becoming more important as CT contrast media use increases. These devices support imaging workflows and carry higher ASPs than conventional products.
Their growing use is shifting market value toward premium long-term access devices.
Safety Device Conversion
Safety devices are expected to become the standard of care in many vascular access procedures. Legislative requirements and needlestick prevention efforts are supporting continued conversion.
Future adoption in countries without strong safety mandates could create additional growth.
Tip-Placement Support
Tip-placement systems and accessories are gaining importance as providers focus on accurate catheter placement and workflow efficiency.
These systems can help reduce placement uncertainty and support more consistent vascular access procedures.
Infection Prevention
Infection prevention remains central to vascular access care. Antibacterial catheter patches, catheter caps, and securement products help reduce infection risk and support safer access management.
This trend is especially important in central venous and dialysis access.
Long-Term Access Growth
Higher-value devices such as implantable ports, PICCs, and midlines are becoming more important to total market value. These products support longer dwell times and more specialized therapy needs.
Their growth reflects a shift away from basic short-term access toward more tailored access strategies.
Mature Consumable Competition
High-volume consumables, including PIVCs, syringes, and needles, face mature demand and strong price pressure. Companies competing in these categories must manage volume, procurement expectations, and safety conversion.
This trend limits ASP growth in basic product categories.
Geography
This report provides global coverage across North America, Europe, Asia-Pacific, Latin America, the Middle East, and Africa.
The Global Vascular Access Device Market Report from iData Research answers these questions with device-level analysis, procedure-based modeling, ASP data, company share insights, and forecasts through 2032. Use it to evaluate demand, benchmark competitors, understand product mix shifts, and support commercial planning in the global vascular access device market.
Global Vascular Access Market Overview
Competitive Analysis
Market Trends
Market Developments
Procedures Included
Markets Included
Regions Included
Key Report Updates
Version History
Global Vascular Access Market Overview